Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 181

Similar articles for PubMed (Select 15324907)

1.

Design and synthesis of substituted N-methylbenzamide analogues derived from SR 48,968 as neurokinin-2 receptor antagonists.

Huang SC, Undem B, Korlipara V.

Bioorg Med Chem Lett. 2004 Sep 20;14(18):4779-82.

PMID:
15324907
2.

Design and synthesis of 3,5-disubstituted benzamide analogues of DNK333 as dual NK1/NK2 receptor probes.

Swarna VM, Undem BJ, Korlipara VL.

Bioorg Med Chem Lett. 2007 Feb 15;17(4):890-4. Epub 2006 Dec 1.

PMID:
17169559
3.

4-Alkylpiperidines related to SR-48968: potent antagonists of the neurokinin-2 (NK2) receptor.

Jacobs RT, Shenvi AB, Mauger RC, Ulatowski TG, Aharony D, Buckner CK.

Bioorg Med Chem Lett. 1998 Jul 21;8(14):1935-40.

PMID:
9873462
5.

The design and synthesis of novel NK1/NK2 dual antagonists.

Reichard GA, Ball ZT, Aslanian R, Anthes JC, Shih NY, Piwinski JJ.

Bioorg Med Chem Lett. 2000 Oct 16;10(20):2329-32.

PMID:
11055349
7.

4-Amino-2-(aryl)-butylbenzamides and Their conformationally constrained analogues. Potent antagonists of the human neurokinin-2 (NK(2)) receptor.

MacKenzie AR, Marchington AP, Middleton DS, Newman SD, Selway CN, Terrett NK.

Bioorg Med Chem Lett. 2003 Jul 7;13(13):2211-5.

PMID:
12798336
8.

Spiro-substituted piperidines as neurokinin receptor antagonists. III. Synthesis of (+/-)-N-[2-(3,4-dichlorophenyl)-4-(spiro-substituted piperidin-1'-yl)butyl]-N-methylbenzamides and evaluation of NK1-NK2 dual antagonistic activities.

Kubota H, Kakefuda A, Okamoto Y, Fujii M, Yamamoto O, Yamagiwa Y, Orita M, Ikeda K, Takeuchi M, Shibanuma T, Isomura Y.

Chem Pharm Bull (Tokyo). 1998 Oct;46(10):1538-44.

PMID:
9810691
9.

Tachykinin NK(2) receptors facilitate acetylcholine release from guinea-pig isolated trachea.

D'Agostino G, Erbelding D, Kilbinger H.

Eur J Pharmacol. 2000 May 12;396(1):29-32.

PMID:
10822050
10.

Discovery of novel, orally active dual NK1/NK2 antagonists.

Bernstein PR, Aharony D, Albert JS, Andisik D, Barthlow HG, Bialecki R, Davenport T, Dedinas RF, Dembofsky BT, Koether G, Kosmider BJ, Kirkland K, Ohnmacht CJ, Potts W, Rumsey WL, Shen L, Shenvi A, Sherwood S, Stollman D, Russell K.

Bioorg Med Chem Lett. 2001 Oct 22;11(20):2769-73.

PMID:
11591520
11.

NK(2)-receptor mediated contraction in monkey, guinea-pig and human airway smooth muscle.

Rizzo CA, Valentine AF, Egan RW, Kreutner W, Hey JA.

Neuropeptides. 1999 Feb;33(1):27-34.

PMID:
10657468
12.

Mutagenesis at the human tachykinin NK(2) receptor to define the binding site of a novel class of antagonists.

Meini S, Bellucci F, Catalani C, Cucchi P, Patacchini R, Rotondaro L, Altamura M, Giuliani S, Giolitti A, Maggi CA.

Eur J Pharmacol. 2004 Mar 19;488(1-3):61-9.

PMID:
15044036
13.

Pharmacologic evaluation of neurokinin-2 receptor antagonists in the guinea pig respiratory tract.

Venugopal CS, Christopher CL, Wilson SM, Polikepahad S, Dequeant E, Holmes EP.

Am J Vet Res. 2004 Jul;65(7):984-91.

PMID:
15281659
14.

Modulation on C- and N-terminal moieties of a series of potent and selective linear tachykinin NK(2) receptor antagonists.

Gensini M, Altamura M, Dimoulas T, Fedi V, Giannotti D, Giuliani S, Guidi A, Harmat NJ, Meini S, Nannicini R, Pasqui F, Tramontana M, Triolo A, Maggi CA.

ChemMedChem. 2010 Jan;5(1):65-78. doi: 10.1002/cmdc.200900389.

PMID:
19957262
15.

SR 142801, a tachykinin NK(3) receptor antagonist, prevents beta(2)-adrenoceptor agonist-induced hyperresponsiveness to neurokinin A in guinea-pig isolated trachea.

Pinto FM, Saulnier JP, Faisy C, Naline E, Molimard M, Prieto L, Martin JD, Emonds-Alt X, Advenier C, Candenas ML.

Life Sci. 2002 Dec 6;72(3):307-20.

PMID:
12427489
16.

Airway responses to capsaicin in guinea pigs: role of NK-1 and NK-2 neurokinin receptors.

Vieira JE, Warth Mdo P, Leme AS, Maldonado EA, King M, Saldiva PH, Martins MA.

Exp Lung Res. 1997 Jan-Feb;23(1):85-99.

PMID:
9028801
17.

Depressed contractile responses to neurokinin A in idiopathic but not neurogenic overactive human detrusor muscle.

Sellers DJ, Chapple CR, W Hay DP, Chess-Williams R.

Eur Urol. 2006 Mar;49(3):510-8. Epub 2006 Jan 6.

PMID:
16420969
18.

Spiro-substituted piperidines as neurokinin receptor antagonists. II. Syntheses and NK2 receptor-antagonistic activities of N-[2-aryl-4-(spiro-substituted piperidin-1'-yl)butyl]carboxamides.

Kubota H, Kakefuda A, Nagaoka H, Yamamoto O, Ikeda K, Takeuchi M, Shibanuma T, Isomura Y.

Chem Pharm Bull (Tokyo). 1998 Feb;46(2):242-54.

PMID:
9501460
19.

Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonists.

Blaney FE, Raveglia LF, Artico M, Cavagnera S, Dartois C, Farina C, Grugni M, Gagliardi S, Luttmann MA, Martinelli M, Nadler GM, Parini C, Petrillo P, Sarau HM, Scheideler MA, Hay DW, Giardina GA.

J Med Chem. 2001 May 24;44(11):1675-89.

PMID:
11356103
20.

Identification of a novel 1'-[5-((3,5-dichlorobenzoyl)methylamino)-3-(3,4-dichlorophenyl)-4-(methoxyimino)pentyl]-2-oxo-(1,4'-bipiperidine) as a dual NK(1)/NK(2) antagonist.

Ting PC, Lee JF, Shih NY, Piwinski JJ, Anthes JC, Chapman RW, Rizzo CA, Hey JA, Ng K, Nomeir AA.

Bioorg Med Chem Lett. 2002 Aug 19;12(16):2125-8.

PMID:
12127519
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk